CClinicalTrials.gg
CompletedNCT05107726Updated May 20, 2026Results posted

Piloting a Family-Based Intervention of Time-Restricted Eating to Treat Obesity

An interventional study of TRE Group in Childhood Obesity, sponsored by University of Minnesota. Completed at 1 site in United States. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2026-05-20.

Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
3 Years and older
Sex
All
01

Study summary

This study will test whether managing the hours during which people eat, called time restricted eating, might help them to lose weight. For this study, one parent and a child will enroll as a group (called a dyad).

The dyads will be assigned at random to practice time restricted eating (within 10-12 hours per day) but will be able to eat whatever they would like or to limit portion size and increase fruit, vegetable and lean protein intake and limit sugar sweetened beverages and undergo . Both groups will receive dietary counseling, Bluetooth toothbrushes and scales to help monitor their progress.

The study will last for 12 weeks and will have one survey four weeks after the last in person visit. There will be 2 in person visits, 7 virtual visits, 2 phone visits and daily time logs.

Read the detailed description

This study will provide preliminary data to demonstrate feasibility and acceptability of time-restricted eating (TRE) in the family unit, providing critical preliminary data to support NIH-level funding for a more detailed analysis of TRE in families.

Obesity affects over 40% of adults and over 25% of children in the United States. Obesity - defined in adults as a body mass index (BMI) > 30 kg/m2 and in children as BMI > 95th percentile - is associated with several physical and psychological comorbidities, such as hypertension, heart disease, type 2 diabetes mellitus, and reduced quality of life. Heritability of obesity is 40-75%. Thus, if a parent is obese, children in the family have a high likelihood of also becoming obese due to both genetic and environmental factors. As such, treatments that apply to the family unit can address the public health concern of obesity at the child and adult level.

Typically, obesity treatment primarily focuses on intentional caloric restriction. In adults with obesity, behavior-based weight loss programs result in weight reduction of 1-4 kg over one year. In children with obesity, lifestyle modification therapy typically results in weight stabilization, while children without treatment gain weight. Weight stabilization results in reductions in body mass index parameters (e.g., percent BMI or BMI z-score) due to increased height in children. Family-based obesity treatment also focuses on intentional caloric restriction through reduced consumption of energy dense foods, as well as increased consumption of low energy density foods, increased physical activity, and implementation of strategic parenting practices. Parent BMI change is a significant predictor of child outcomes in family-based treatment. Unfortunately, family-based interventions are typically time and resource intensive, thus limiting their receptiveness by many families.

In contrast to intentionally restricting calories, time-restricted eating (TRE) intentionally restricts the eating window while allowing ad libitum intake during the window. TRE's agnostic approach to eating allows individuals to select foods that align with their needs and preferences. Multiple studies in adults, including our own, demonstrate TRE reduces weight. The postulated mechanism is that a reduced eating window reduces the number of eating occasions to reduce daily caloric intake.

02

Conditions studied

  • Childhood Obesity

Browse trials for

03

In context

Pediatric Obesity

1,117 studies on the registry are indexed under Pediatric Obesity; 189 are open to participants now.

This study's enrollment of 36 is below the median of 103 across 862 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • BMI >/= 30 kg/m2 for the parent
  • BMI > 95th percentile for the child
  • Age 3-9 years for the child
  • Age >/= 18 years old for the parent

Exclusion criteria

Exclusion Criteria:

  • Concurrent participation in another weight loss study
  • Taking any medications for weight loss
  • Pregnancy or anticipation of pregnancy in next 6 months (for the parent)
  • 3+ on Eating Disorder Survey
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    TRE Group

    In the TRE group, study staff will instruct the family unit on limiting the eating window to 10-12 hours per day, during which they can eat ad libitum. Notably, in the TRE group, participants (children and adults) will be instructed to brush their teeth with a WIFI-enabled toothbrush in the morning and specifically within ½ hour after their evening meal. This will serve as a cue to stop evening eating, and information from the WIFI-enabled toothbrush will be accessed by study staff to approximate the eating window. The adult from each family unit will receive a daily REDCap-administered email to indicate the timing of the first meal of the day and the last meal of the day for the parent and child, which will also serve as an estimate of the eating window.

    Behavioral: TRE Group

  • No intervention
    Standard of Care Group

    The standard of care control group will receive dietary instruction that is based on a 1200-1500 calorie diet, as is typical of family-based interventions. Calorie counting will not be encouraged. However, families will be encouraged to follow appropriate portion sizes; increase vegetable, fruit and lean protein consumption; as well as decrease consumption of energy-dense but low-quality items (e.g., sugar sweetened beverages). Families in this group will also receive a WIFI-enabled toothbrush and daily REDCap surveys but will not be instructed on when to brush teeth or to shorten their eating window

Interventions

  • BehavioralTRE Group

    This group will practice time-restricted eating

06

What researchers measure

Primary outcomes

  1. Change in BMI for Pediatric Participants

    Change in baseline BMI (kg/m\^2) among pediatric participants.

    Time frame: Change from baseline to 12 weeks. Table contains CHILDREN only.

Secondary outcomes

  1. Change in Body Mass Index (BMI) in Adult Participants

    Change from baseline in BMI (kg/m\^2) among Adult participants. Results table contains PARENTS only.

    Time frame: Baseline to 12 weeks

07

Results

Posted May 20, 2026

Participant flow

Recruitment letters were mailed to child participants within our health system based on an initial screening of eligibility of their electronic health record. This study also utilized recruitment flyers and posters that were posted in the community. Both the child participant and their parent participated in the study as a dyad. Results are posted by randomization group for each participant with the exception of the age, where results are broken down by the adult and child within each dyad.

Participant flow — Overall Study
MilestoneTRE GroupStandard of Care Group
Started2016
Completed2016
Not completed00

Outcome measures

PrimaryChange in BMI for Pediatric Participants

Change in baseline BMI (kg/m\^2) among pediatric participants.

Time frame:
Change from baseline to 12 weeks. Table contains CHILDREN only.
Reported as:
Mean · BMI (weight in kg/height in m^2)
Change in BMI for Pediatric Participants
BMI (weight in kg/height in m^2)TRE GroupStandard of Care Group
Change in BMI for Pediatric Participants-0.7 ± 4.6-0.9 ± 1.4
SecondaryChange in Body Mass Index (BMI) in Adult Participants

Change from baseline in BMI (kg/m\^2) among Adult participants. Results table contains PARENTS only.

Time frame:
Baseline to 12 weeks
Reported as:
Mean · BMI (weight in kg/height in m^2)
Change in Body Mass Index (BMI) in Adult Participants
BMI (weight in kg/height in m^2)TRE GroupStandard of Care Group
Change in Body Mass Index (BMI) in Adult Participants0.4 ± 1.1-1.3 ± 0.7

Adverse events

Collected over As this study was related to timed eating and tooth brushing habits, which are not greater than minimal risk, no adverse events or serious adverse events were monitored or assessed. All Cause mortality also was not monitored or assessed.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
TRE Group———
Standard of Care Group———

Baseline characteristics

This study enrolled dyads consisting of one parent and one child. A total of 20 individuals were randomized to the TRE group (10 dyads) and 16 individuals were randomized to the standard of care group (8 dyads). All 36 participants had BMI calculations completed for the study.

Age, Continuous
Age, Continuous(years)TRE GroupStandard of Care GroupTotal
Age of Parent37.777 ± 6.92440.125 ± 5.91438.882 ± 6.382
Age of Child7.4 ± 1.5776.625 ± 1.4077.055 ± 1.513
Sex: Female, Male
Sex: Female, Male(Participants)TRE GroupStandard of Care GroupTotal
Gender of Parent — Female8816
Gender of Parent — Male202
Gender of Child — Female6410
Gender of Child — Male448
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)TRE GroupStandard of Care GroupTotal
Parent Ethnicity — Hispanic or Latino202
Parent Ethnicity — Not Hispanic or Latino8715
Parent Ethnicity — Unknown or Not Reported011
Child Ethnicity — Hispanic or Latino404
Child Ethnicity — Not Hispanic or Latino6713
Child Ethnicity — Unknown or Not Reported011
Race (NIH/OMB)
Race (NIH/OMB)(Participants)TRE GroupStandard of Care GroupTotal
Race of Parent — American Indian or Alaska Native000
Race of Parent — Asian123
Race of Parent — Native Hawaiian or Other Pacific Islander000
Race of Parent — Black or African American101
Race of Parent — White8513
Race of Parent — More than one race000
Race of Parent — Unknown or Not Reported011
Race of Child — American Indian or Alaska Native000
Race of Child — Asian123
Race of Child — Native Hawaiian or Other Pacific Islander000
Race of Child — Black or African American112
Race of Child — White7310
Race of Child — More than one race101
Race of Child — Unknown or Not Reported022
Region of Enrollment
Region of Enrollment(Participants)TRE GroupStandard of Care GroupTotal
United States201636
08

Study locations

1 site
  • University of Minnesota, Delaware Clinical Research Unit
    Minneapolis, Minnesota 55414, United States
09

References and documents

Publications

  • Gross AC, Helgeson ES, Wang Q, Chow LS. Pilot Randomised Controlled Trial of the Feasibility and Acceptability of Family-Based Time Limited Eating to Treat Obesity. Pediatr Obes. 2026 Mar;21(3):e70103. doi: 10.1111/ijpo.70103. PubMed 41857344 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 7, 2022
  • Informed consent form · Jan 12, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05107726
Lead sponsor
University of Minnesota
Responsible party
Sponsor
First posted
Nov 4, 2021
Start date
Mar 30, 2022
Primary completion
Sep 13, 2023
Completion
Sep 13, 2023
Results posted
May 20, 2026
Last update
May 20, 2026

Study contacts

Amy Gross, PhD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion